Search

Your search keyword '"Liao, K"' showing total 8 results
Start Over Author "Liao, K" Journal annals of oncology
8 results on '"Liao, K"'

1. 142P Effectiveness and safety of pegylated liposomal doxorubicin- cyclophosphamide vs. epirubicin-cyclophosphamide as adjuvant chemotherapy for stage I and II HER2-negative breast cancer: An interim analysis of phase II randomized trial

Author

Tseng, L-M., primary, Chen, F-M., additional, Chen, S-T., additional, Cheng, T-F., additional, Chao, T-Y., additional, Dai, M-S., additional, Kao, W-Y., additional, Chen, D-R., additional, Liu, L-C., additional, Wang, H.C., additional, Chang, H-T., additional, Wang, B.W., additional, Yu, J-C., additional, Chen, S.C., additional, Liao, K-H., additional, and Hou, M-F., additional

Published
2022
Full Text
View/download PDF

4. 46P AB521, a clinical-stage, potent, and selective Hypoxia-Inducible Factor (HIF)-2α inhibitor, for the treatment of renal cell carcinoma

Author

Lawson, K.V., primary, Sivick Gauthier, K.E., additional, Piovesan, D., additional, Mailyan, A., additional, Mata, G., additional, Fournier, J.T.A., additional, Yu, K., additional, Liu, S., additional, Soriano, F., additional, Jin, L., additional, Ginn, E., additional, Schweickert, P.G., additional, Meleza, C.A., additional, Pham, A., additional, Seitz, L., additional, Liao, K., additional, Paterson, E., additional, Foster, P., additional, Walters, M.J., additional, and Leleti, M., additional

Published
2022
Full Text
View/download PDF

5. Safety, pharmacokinetics (PK) and pharmacodynamics (PD) data from a phase I dose-escalation study of OX40 agonistic monoclonal antibody (mAb) PF-04518600 (PF-8600) in combination with utomilumab, a 4-1BB agonistic mAb

Author

Hamid, O., primary, Ros, W., additional, Thompson, J.A., additional, Hu-Lieskovan, S., additional, Eskens, F.A.L.M., additional, Diab, A., additional, Doi, T., additional, Wasser, J., additional, Spano, J-P., additional, Rizvi, N.A., additional, Angevin, E., additional, Chiappori, A., additional, Ott, P.A., additional, Ganguly, B.J., additional, Fleener, C., additional, Dell, V., additional, Liao, K., additional, Joh, T., additional, Chou, J., additional, and El-Khoueiry, A., additional

Published
2017
Full Text
View/download PDF

7. 1142PD - Safety, pharmacokinetics (PK) and pharmacodynamics (PD) data from a phase I dose-escalation study of OX40 agonistic monoclonal antibody (mAb) PF-04518600 (PF-8600) in combination with utomilumab, a 4-1BB agonistic mAb

Author

Hamid, O., Ros, W., Thompson, J.A., Hu-Lieskovan, S., Eskens, F.A.L.M., Diab, A., Doi, T., Wasser, J., Spano, J-P., Rizvi, N.A., Angevin, E., Chiappori, A., Ott, P.A., Ganguly, B.J., Fleener, C., Dell, V., Liao, K., Joh, T., Chou, J., and El-Khoueiry, A.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results